Cancer BiologybioRxivPreprint
Harnessing patient-specific response dynamics to optimize evolutionary therapies for metastatic clear cell renal cell carcinoma - Learning to adapt
I. C. Sorribes, A. Basu, R. Brady…·H. Enderling
This paper develops a dynamic tumor-immune model to predict patient response to treatment using NLR as a biomarker and simulates optimal therapies for virtual RCC patients.
DOI 10.1101/563130